MSCs are recruited at the tumor site in response to various chemokines, such as CCL2 or CXCL12, secreted by CD133+ tumor stem cells, as demonstrated in mice bearing glioblastomas [34]. This evidence concerns the gene CCL2 and glioblastoma.